
Indegene expands on significant presence by adding to existing UK, Ireland, and Switzerland centers.

Indegene expands on significant presence by adding to existing UK, Ireland, and Switzerland centers.

In its ninth year, the survey includes the opinions of over 240 US-based patient groups on the performance of the pharmaceutical industry in 2021.

The HBA announced the 2023 Woman of the Year, Honorable Mentor, and STAR recipients.

The Anglo-Swedish drugmaker on Monday agreed to pay $26 per CinCor share in cash, or $1.3 billion in total, a premium of nearly 121% to the U.S.-based company's closing price on Friday.

Baker spoke on topics ranging from pricing, access, the war for talent, and other key areas that are impacting pharma companies.

AI continued to grow over the last year, and more life sciences companies are embracing the new technology in a variety of ways.

Personalized medicine continued its growth over the past year and became one of the most talked about topics in the life sciences industry.

Over the past year, the life sciences industry has experienced a variety of important innovations, while also facing an unstable economy. These factors were clearly on readers minds and helped shape the top stories of the year.

Marchesini will serve as Senior Vice President to help life sciences companies improve the effectiveness and efficiency of their commercial processes and go-to-market approach.

Katya Petrova will be responsible for providing JUICE clients with direction and oversight from inception through execution.

The FDA tapped the Reagan-Udall Foundation to launch the initiative.

Lang spoke with Pharm Exec about how recent market conditions impacted pharma this year and how things may change in the coming year.

Amgen spending big to dive deeper into rare disease treatments through deal for drugmaker Horizon Therapeutics.

Inc. 2022 Best in Business Award marks health-focused TogoRun's second year as an independent, woman-owned agency.

Built on Algorand, and in partnership with the Government of Maharashtra in India, NFT technology will be used for storing personal health data for the first time.

Brand Institute, naming agency, shares insights on emerging clinical trial naming trends.

The move bolsters Evoke’s digital innovation and omnichannel offering.

The International Federation of Pharmaceutical Manufacturers and Associations commissioned Ipsos to perform the research.

Over half of life sciences companies are not fully optimizing HCP engagement, according to the study.

Tech company Evermed provides modular content hubs that power personalized video content delivery for life science companies and HCPs.

The initiative taps global social influencers and shares resources, so young men can better understand the benefits of therapy.

The transaction allows TherapeuticsMD to recapitalize and transform into a pharmaceutical royalty company while giving Mayne Pharma exclusive U.S. commercialization rights for their products.

CVS is testing a system that allows pharmacists to process prescriptions remotely to help address pharmacist shortage.

Roku's Chris Schneider discusses how pharmaceutical marketers are still missing a huge population: the cord cutters.

Pfizer CEO Albert Bourla, Ph.D., is in trouble for "misleading" and "overly promotional" claims he made during a BBC interview late last year about their COVID-19 vaccine for younger kids, which was not approved at the time.

With biopharma sales and marketing changing faster than ever, it’s become crucial for brands to stay relevant with each new product launch. Christopher Price shares his point of view through the lens of 20 years of experience in the space.

Building on Morgan Health’s accountable care strategy, Dr. Pegus will help inform the team’s renewed focus on population-based health initiatives, including investing in and scaling promising new care delivery models designed to improve health outcomes, particularly among diverse populations.

80% of Rx Patients Currently See Providers with Access to POC Media.


This is the intelligence company's fifth acquisition.